Why is Venmax Drugs falling/rising?

As of 10-Sep, Venmax Drugs & Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at Rs 24.00, which reflects a decrease of Rs 1.2 or 4.76%. The stock has underperformed its sector by 5.14% today, with an intraday high of Rs 26.46 and a low of Rs 23.96, indicating significant volatility. Over the past week, the stock has seen a substantial drop of 12.28%, and over the past month, it has decreased by 17.72%. Despite a year-to-date increase of 33.04%, the recent performance suggests a negative trend. The stock is trading above its 200-day moving average but below its shorter-term moving averages, indicating mixed signals. Additionally, there has been a notable increase in investor participation, with delivery volume rising by 2257.89% against the 5-day average, which may suggest some interest despite the price drop.
In the broader market context, the Sensex has shown a positive return of 1.06% over the past week and 1.96% over the past month, contrasting sharply with Venmax's negative performance. This divergence indicates that while the overall market is gaining, Venmax is struggling significantly. The liquidity of the stock appears adequate for trading, as it is based on 2% of the 5-day average traded value. However, without specific positive or negative factors available, it is challenging to pinpoint the exact reasons behind the stock's recent decline beyond the performance metrics and market conditions.